all report title image
  • Published On : Dec 2018
  • Code : CMI2396
  • Industry : Pharmaceutical
  • Pages : 152
  • Formats :
Ingographics Image

Acetazolamide is an enzyme inhibitor, which acts specifically on carbonic anhydrase. Acetazolamide, sold under the trade name Diamox, is used to treat glaucoma, altitude sickness, epilepsy, fluid retention, heart failure, and seizures.

In addition to this, acetazolamide (carbonic anhydrase inhibitor) is effective in controlling fluid secretions, to treat certain convulsive disorders, and promotes diuresis in instances of abnormal fluid retention such as cardiac edema.

Increasing effectiveness of acetazolamide in treating other indication such as drug induced edema and brain tumor glioblastoma is offering growth prospective for key drug manufacturers in this market. For instance, according to a new study published in Science Translational Medicine Journal in July 2018, acetazolamide may also be effective in treating glioblastoma, fast-growing brain tumor. As per the study findings, acetazolamide can restore temozolomide’s (TMZ) ability to kill tumor cells. Furthermore, the study suggested that the combination of acetazolamide with TMZ may be an effective subgroup to consider for trial for patients with high BCL-3 expression.

Market Dynamics

Increasing prevalence of glaucoma and its risk factors among global population is propelling demand for acetazolamide during the forecast period. Moreover, acetazolamide is commonly used for preventing high altitude illness, this increases the utility of the drug. 

For instance, according to the International Journal of Advanced Medical and Health Research, 2015, glaucoma is seen to be the second major reason causing blindness among people across the world, followed by cataract.

Furthermore, according to the BrightFocus Foundation, June 2017 data findings, over 3 million Americans suffer from glaucoma, out of which 2.7 million (aged 40 and older) are affected by its most common form, open-angle glaucoma. Also, high prevalence of eye disorder in the geriatric population and nutritional deficiency in the younger population due to changing food habits are other factors affecting the health of the people globally, which might lead to boost growth of acetazolamide market. Acetazolamide capsule taken once a day by patients with chronic glaucoma offers a substantial pressure-lowering effect, which lasts at least 23 hours.

Acetazolamide helps in preventing acute mountain sickness and has fewer side effects than alternative drugs such as dexamethasone, which can mask symptoms and therefore carries greater risk.  

Key features of the study:

  • This report provides in-depth analysis of acetazolamide market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, drug approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global acetazolamide market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as part of this study include Teva Pharmaceutical Industries Ltd., Accord Healthcare Ltd. (Intas Pharmaceuticals Limited), Heritage Pharmaceuticals Inc., Nostrum Laboratories Inc., Novast Laboratories Ltd., Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.), Lannett Company, Inc., Strides Shasun Limited, and X-GEN Pharmaceuticals, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future drug launch, manufacturing up-gradation, market expansion, and marketing tactics
  • The global acetazolamide market report caters to various stakeholders in this industry including investors, suppliers, acetazolamide based product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the acetazolamide market.

Detailed Segmentation:

  • Global Acetazolamide Market, By Formulation:
    • Tablets
    • Capsules
    • Injection
  • Global Acetazolamide Market, By Application:
    • Glaucoma
    • Epilepsy
    • Drug-induced Edema 
    • Altitude Sickness
    • Fluid Retention
    • Heart Failure
    • Seizures  
  • Global Acetazolamide Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Acetazolamide Market, By Geography:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Formulation:
        • Tablets
        • Capsules
        • Injection
      • By Application
        • Glaucoma
        • Epilepsy
        • Drug-induced Edema
        • Altitude Sickness
        • Fluid Retention
        • Heart Failure
        • Seizures
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Europe
      • By Country:
        • Germany
        • France
        • Italy
        • UK
        • Spain
        • Russia
        • Rest of Europe
      • By Formulation:
        • Tablets
        • Capsules
        • Injection
      • By Application
        • Glaucoma
        • Epilepsy
        • Drug-induced Edema
        • Altitude Sickness
        • Fluid Retention
        • Heart Failure
        • Seizures
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • South Korea
        • Australia
        • Rest of Asia Pacific
      • By Formulation:
        • Tablets
        • Capsules
        • Injection
      • By Application
        • Glaucoma
        • Epilepsy
        • Drug-induced Edema
        • Altitude Sickness
        • Fluid Retention
        • Heart Failure
        • Seizures
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Formulation:
        • Tablets
        • Capsules
        • Injection
      • By Application
        • Glaucoma
        • Epilepsy
        • Drug-induced Edema
        • Altitude Sickness
        • Fluid Retention
        • Heart Failure
        • Seizures
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Latin America
      • By Country:
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
      • By Formulation:
        • Tablets
        • Capsules
        • Injection
      • By Application
        • Glaucoma
        • Epilepsy
        • Drug-induced Edema
        • Altitude Sickness
        • Fluid Retention
        • Heart Failure
        • Seizures
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • By Formulation:
        • Tablets
        • Capsules
        • Injection
      • By Application
        • Glaucoma
        • Epilepsy
        • Drug-induced Edema
        • Altitude Sickness
        • Fluid Retention
        • Heart Failure
        • Seizures
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Strategies
    • Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
    • Heritage Pharmaceuticals Inc.
    • Nostrum Laboratories Inc.
    • Novast Laboratories Ltd.
    • Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.)
    • Lannett Company, Inc.
    • Strides Shasun Limited
    • X-GEN Pharmaceuticals, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Formulation
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Epidemiology
    • Key Developments
    • Drug Approvals and Launches
    • Strategic Collaborations & Acquisitions
    • Regulatory Scenario
    • Pipeline Analysis
  4. Global Acetazolamide Market, By Formulation, 2018 - 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Tablets
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Capsules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  5. Global Acetazolamide Market, By Application, 2018 - 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Glaucoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Epilepsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Drug indicted Edema 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Altitude Sickness
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Fluid Retention
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Heart Failure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Seizures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  6. Global Acetazolamide Market, By Distribution Channel, 2018 - 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Hospital Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Retail Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  7. Global Acetazolamide Market, By Region, 2018 - 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • North America
      • Market Size and Forecast, By Formulation, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Formulation, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Formulation, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Formulation, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Formulation, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Formulation, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Heritage Pharmaceuticals Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Nostrum Laboratories Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Novast Laboratories Ltd.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.)
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Lannett Company, Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Strides Shasun Limited
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • X-GEN Pharmaceuticals, Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 23 market data tables and 25 figures on "Acetazolamide Market - Global forecast to 2026”.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo